In type 2 diabetes, improving glycemic control may decrease dementia risk.
EASD 2015 Complete Coverage
Patients with type 2 diabetes may benefit from a high-protein diet.
A closed-loop system improved glucose control, reduced hypoglycemia in type 1 diabetes.
Empagliflozin linked to lower risk for hospitalizations for heart failure and CV death in type 2 diabetes patients with high CVD risk.
Women with diabetes more likely to have heart disease than men.
Young children without garden access more likely to be obese.
Risk for diabetes increased by more than 40%.
Women exposed in early pregnancy have four times the risk for gestational diabetes.
Researcher reports on 3-year-old girl with type 2 diabetes.
Exposure associated with a 61% increased risk for diabetes.
Prevention of cardiovascular events in women with diabetes should be approached differently from men with the disease.
Sign Up for Free e-Newsletters
Check out what's trending
Endocrinology Advisor Articles
- Subclinical Hypothyroidism: Controversies in Testing and Treatment
- Favorable Outcomes With Second-Generation Insulin Analogs in Type 2 Diabetes
- Canagliflozin Trial for T2D With CKD Stopped Early Due to Positive Results
- Type 2 Diabetes and Alzheimer Disease: What's the Connection?
- Risk for Hypoglycemia During Titration With Insulin Glargine 100 U/mL in T2D
- Using Latent Class Trajectory Analysis to Determine Glucose Response Curve Patterns
- First CGM System With Implantable Glucose Sensor Approved
- Empagliflozin, Linagliptin Combination Therapy vs Linagliptin Monotherapy for Type 2 Diabetes
- Risk for Below Knee Amputations With Canagliflozin vs Other Antihyperglycemic Agents
- Two Phases of C-Peptide Decline Identified in Type I Diabetes
- Effect of SGLT2 Inhibitors on Heart Failure-Related Hospitalization, Below-Knee Amputation
- Nutraceuticals Containing Equol May Be Effective for Postmenopausal Symptoms
- Conservative Monitoring Strategy for Non-Functioning Pituitary Adenomas Evaluated
- FDA: Some Rx Drugs May Become Available Without Seeing a Doctor
- PM2.5 Contributes to Burden of Diabetes Mellitus Globally